With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.
This is a preview of subscription content, log in via an institution to check access.
References
Torres, D. M., Williams, C. D. & Harrison, S. A. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 10, 837–858 (2012).
Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142, 1592–1609 (2012).
Verma, S., Jensen, D., Hart, J. & Mohanty, S. R. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. http://dx.doi.org/10.1111/liv.12226.
Amarapurka, D. N. et al. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann. Hepatol. 5, 30–33 (2006).
Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131 (2011).
Francanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48, 792–798 (2008).
Lee, J. Y. et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living donors in Korea: a review of 589 consecutive liver biopsies in a single center. J. Hepatol. 47, 239–244 (2007).
Schindhelm, R. K. et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab. Res. Rev. 22, 437–443 (2006).
Bedogni, G. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).
Hamaguchi, M. et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 102, 2708–2715 (2007).
Acknowledgements
The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of San Antonio Military Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, Department of Defense or the U.S. Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Torres, D., Harrison, S. Predictive value of ALT levels for NASH and advanced fibrosis. Nat Rev Gastroenterol Hepatol 10, 510–511 (2013). https://doi.org/10.1038/nrgastro.2013.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.138
- Springer Nature Limited
This article is cited by
-
Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up
BMC Gastroenterology (2024)
-
The association of adiponectin gene polymorphisms with susceptibility and progression of NAFLD in a cohort of Egyptian patients
Egyptian Liver Journal (2021)
-
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease
Hepatology International (2020)
-
Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
Scientific Reports (2015)